Biologics - Shaping the Future of Drug Discovery and Development

Premier Source of Biotech, Medical & Life Science Market Research Reports

RIT's Biologics Market Research Update (November 2015) analyzes this tremendously potential field that can treat and cure several diseases.

Biologics for rheumatic diseases, which focus on molecules concerned with the techniques connected with immune systems, offer a good option to the current treatment procedures for autoimmune diseases.
— Anasuya Vemuri
HYDERABAD, TELANGANA, INDIA, December 4, 2015 /EINPresswire.com/ -- Research Impact Technologies' latest update on Biologics market provides an exclusive insight into this field of complex medications. Global Biologics market is projected to grow at 9.33% compounded annually from 2005 through 2020. Blood and blood products are the major product area with tremendous potential and growth. Automated blood collection and processing systems as well as prior-screening capabilities of latest assays are expected to enhance quantity and quality of blood. Since the last decade, the therapeutic market for monoclonal antibodies has grown exponentially. Bevacizumab, Trastuzumab, Adalimumab, Infliximab and Rituximab are the top five therapeutic antibodies available. About 40% of the best selling biopharmaceuticals are therapeutic monoclonal antibodies. Development of vaccines has proved to be crucial and effective in the pharmaceutical industry. Growing human and animal populations and advancement of science and technology are the driving factors behind the global vaccines market. High prevalence of diabetes, treatment and diagnosis rates, device penetration and changes in price are driving the human insulin market. Biologics market holds tremendous potential and promise.

Since the approval of insulin as the first recombinant therapeutic protein, biologic therapies in drug development have gained immense significance. Biologics have delivered life changing results. Many unmet medical needs are being addressed for several disease areas using traditional replacement proteins to more recent, highly engineered antibodies, oligonucleotides, fusion proteins, and gene constructs.

The market study analyzes the Biologics market by product type, application area and by disease area. Product types include Monoclonal Antibodies, Blood & Blood Products, Vaccines, Insulin and Other, while application areas are for both human and animal consumption. The disease areas covered include autoimmune diseases, oncology, infectious Diseases, Diabetes and other. The report serves as a guide to Biologics market, covering more than 800 companies that are engaged in Biologics products and services. Major Contract Research Organizations, Research Institutes and Universities serving the Biologics market are also covered in the corporate directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is covered in the report. Compilation of Worldwide Patents related to Biologic products is also provided. A global perspective is presented along with regional analysis covering the regions of North America, Europe, Asia-Pacific, and Rest of World with more than 150 exclusive graphically represented exhibits.

This report may help Drug Developing Companies, Strategists, Investors, Laboratories, Contract Research Organizations, Biotechnology & Healthcare Companies, Academic Professionals, Drug Approval Authorities, and Other Organizations to –

Identify Market Opportunities
Review and Analyze Global and Regional Markets
Gauge Market Potential for Products
Identify Competition
Use Market Research for exploring new areas
Acquire Meaningful Guidelines for Strategic Planning
Gear up for Market Entry
Get Actionable Information


To order this market research report on Biologics, please contact us at contactus@researchimpact.com. You may also explore custom research services on Biologics with RI Technologies.


About RI Technologies

Research Impact Technologies, www.researchimpact.com, is a premier market research provider. The company believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The reports provide strategic information tools that help to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information. Investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools stand to benefit from RI Technologies' unique market research reports.


contactus@researchimpact.com

Anasuya Vemuri
Research Impact Technologies
+91 9676994272
email us here